Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

As more doctors and patients turn to the latest weight-loss drugs, researchers are trying to figure out which drug is right ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...

President Donald Trump said he plans to order a cut in prescription drug costs to bring them in line with other countries, ...

Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

EXCLUSVE: LA-based production company Jingletown will be in Cannes to discuss a slate of projects including films produced ...

Eli Lilly’s weight loss drug Zepbound led to significantly greater weight loss than Novo Nordisk’s Wegovy in a 72-week, head-to-head clinical trial, according to findings published in The New England ...

A review of the film in Variety notes, “Patricia Clarkson can be larger-than-life… but the beauty of her performance in Lilly ...

In secondary endpoints, 64.6% of participants using Zepbound saw 15% weight loss compared with 40.1% on Wegovy. And Zepbound participants saw their waists reduced by an average 7.2 in (18.4 cm), ...

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...

President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...